PTPI
Petros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.00
−34.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.01x
- P/S forward
- 0.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.00x
- PEG TTM
- —
- Price / book
- 0.24x
- Price / sales
- —
- Price / cash flow
- -0.05x
Enterprise value
- Enterprise value
- -$3.3M
- EV / sales
- —
- EV / EBITDA
- 1.31x
- EV / EBIT
- 0.98x
- Market cap
- $169.1K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026